Invention Grant
- Patent Title: Benzimidazole derivatives as MCH receptor antagonists
- Patent Title (中): 苯并咪唑衍生物作为MCH受体拮抗剂
-
Application No.: US14371824Application Date: 2013-01-11
-
Publication No.: US09365540B2Publication Date: 2016-06-14
- Inventor: Shizuo Kasai , Hideyuki Igawa , Masashi Takahashi , Tsuyoshi Maekawa , Keiko Kakegawa , Asato Kina , Jumpei Aida , Uttam Khamrai , Mrinalkanti Kundu
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- International Application: PCT/JP2013/051017 WO 20130111
- International Announcement: WO2013/105676 WO 20130718
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D409/14 ; C07D405/14 ; C07D403/14 ; C07D413/14 ; C07D401/14 ; C07D401/04 ; C07D417/14
Abstract:
The present invention provides an aromatic ring compound having a melanin-concentrating hormone receptor antagonistic action and useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula wherein each symbol as defined in the specification, or a salt thereof.
Public/Granted literature
- US20150018363A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS Public/Granted day:2015-01-15
Information query
